Jared Haase

Jamie Perse

Matthew Gillmor

Benjamin Rossi

Matthew Gilmore

Jason Cassorla

John Stansel

- InnovAge reported strong Q1 2026 financial results with **total revenue of $236.1 million**  **[0001834376_2233376_1]** **[0001834376_2233376_1]** , a **15.1% increase** year-over-year, and **Adjusted EBITDA of $17.6 million**  **[0001834376_2233376_1]** **[0001834376_2233376_1]** , which more than **doubled** compared to Q1 2025.  **[0001834376_2233376_1]** **[0001834376_2233376_1]** **[0001834376_2233376_4]** **[0001834376_2233376_5]**  The company also achieved **positive net income of $7.7 million** for the first time since 2021.  **[0001834376_2233376_2]** **[0001834376_2233376_5]** 
- Census reached an all-time high of **7,890 participants**  **[0001834376_2233376_1]** **[0001834376_2233376_1]** **[0001834376_2233376_4]** , growing **9.4%** compared to Q1 2025 and **1.9%** sequentially  **[0001834376_2233376_4]** , driven by strong medical cost management and better-than-expected Medicaid redetermination cleanup progress.  **[0001834376_2233376_1]** **[0001834376_2233376_1]** 
- The company reaffirmed its fiscal year 2026 guidance, projecting total revenue between **$900 million-$950 million** and Adjusted EBITDA in the range of **$56 million-$65 million**.  **[0001834376_2233376_6]**  Ending census for FY 2026 is expected to be between **7,900 and 8,100 participants**.  **[0001834376_2233376_5]** 
- InnovAge, the largest PACE provider in the country, emphasized the resilience of its integrated care model amidst challenging operating environments for other value-based care models.  **[0001834376_2233376_1]** **[0001834376_2233376_1]**

InnovAge Reports Strong Q1 2026 Results and Reaffirms FY 2026 Guidance

- InnovAge Holding Corp. reported **total revenues of $236.1 million** for the fiscal first quarter ended September 30, 2025, an increase of approximately **15.1%** year-over-year, alongside a shift to **net income of $7.7 million** (or **$0.06 per share**) from a net loss in the prior year period.  **[1834376_0001834376-25-000072_innv-20251104xexx991.htm:0]** **[1834376_0001834376-25-000072_innv-20251104xexx991.htm:1]** 
- **Adjusted EBITDA significantly increased to $17.6 million** in Q1 FY2026, up from $6.5 million in Q1 FY2025.  **[1834376_0001834376-25-000072_innv-20251104xexx991.htm:0]** **[1834376_0001834376-25-000072_innv-20251104xexx991.htm:1]** 
- The company's participant **census grew to approximately 7,890** as of September 30, 2025, compared to 7,210 in the prior year's first quarter.  **[1834376_0001834376-25-000072_innv-20251104xexx991.htm:1]** 
- InnovAge confirmed its **full fiscal year 2026 guidance**, projecting total revenues between **$900 million and $950 million** and Adjusted EBITDA between **$56 million and $65 million**.  **[1834376_0001834376-25-000072_innv-20251104xexx991.htm:2]**

InnovAge Holding (INNV)